OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Providers
  3. Timothy Shaver
⚕️
MDIndividual

Timothy Shaver, MD

NPI: 1336145804
Wichita, KS
10 years of data
Rheumatology
$27.1M
Total Payments
337
Beneficiaries
1.8M
Services
2.43x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$27.1M
Specialty median$352.6K

📋 Key Findings

1Billed $27.1M over 10 years
22.43x markup ratio (above median)
399th percentile in Rheumatology by payments
4702 services/day — physically implausible
57 procedures with >3x markup

⚠️ This provider averages 702 services per working day — physically unusual for an individual practitioner

Based on 1.8M total services over 10 years (250 working days/year). Learn about impossible service volumes →

🔎 Data Analysis

This provider's $27.1M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.

Averaging 702 services per working day raises questions about billing patterns.

Medicare payments to this provider grew 61% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$28.91$14.671.97x$14.24$1.9M127.5K30
2015$42.34$22.031.92x$20.31$2.1M97.5K32
2016$54.14$24.432.22x$29.71$2.3M95.1K29
2017$41.54$19.292.15x$22.25$2.7M137.7K31
2018$35.69$16.632.15x$19.06$2.9M174.3K33
2019$37.09$16.872.20x$20.22$3.1M181.7K40
2020$38.79$15.362.53x$23.43$3.2M205.2K38
2021$39.03$14.282.73x$24.75$3.1M219.8K36
2022$35.32$11.793.00x$23.53$2.8M238.8K33
2023$32.67$10.873.01x$21.80$3.0M277.8K35

Top Procedures (20)

J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
$6.2M
171.4K services$36.10/svc1.84x markup
J1745Injection, infliximab, excludes biosimilar, 10 mg⚠ 3.2x markup
$4.9M
97.6K services$49.84/svc3.20x markup
J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
$3.2M
599.2K services$5.33/svc2.35x markup
J9312Injection, rituximab, 10 mg
$2.5M
36.1K services$68.81/svc2.20x markup
J1602Injection, golimumab, 1 mg, for intravenous use
$2.2M
141.4K services$15.43/svc2.85x markup
J9310Injection, rituximab, 100 mg
$1.9M
3.1K services$601.38/svc1.82x markup
J0897Injection, denosumab, 1 mg
$1.7M
111.2K services$15.26/svc2.18x markup
J3262Injection, tocilizumab, 1 mg
$1.7M
421.7K services$3.93/svc2.04x markup
J3111Injection, romosozumab-aqqg, 1 mg
$683.2K
90.9K services$7.51/svc2.66x markup
99213Established patient office or other outpatient visit, 20-29 minutes
$525.7K
9.9K services$53.07/svc2.16x markup
99214Established patient office or other outpatient visit, 30-39 minutes
$439.0K
6.1K services$72.41/svc2.20x markup
96413Administration of chemotherapy into vein, 1 hour or less
$290.9K
3.0K services$97.62/svc2.82x markup
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less⚠ 3.3x markup
$218.2K
4.3K services$50.86/svc3.27x markup
99204New patient office or other outpatient visit, 45-59 minutes
$83.1K
775 services$107.23/svc2.60x markup
96415Administration of chemotherapy into vein, each additional hour⚠ 6.7x markup
$76.8K
3.6K services$21.46/svc6.69x markup
96372Injection of drug or substance under skin or into muscle⚠ 4.7x markup
$68.0K
5.3K services$12.86/svc4.66x markup
20610Aspiration and/or injection of fluid from large joint⚠ 3.8x markup
$54.3K
1.2K services$45.53/svc3.82x markup
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count⚠ 3.3x markup
$48.7K
6.5K services$7.48/svc3.34x markup
86481Tuberculosis test, enumeration of t-cells
$43.4K
441 services$98.34/svc2.13x markup
J3489Injection, zoledronic acid, 1 mg⚠ 9.9x markup
$38.0K
1.9K services$19.88/svc9.87x markup
Show detailed table ▾
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)171.4K$6.2M$36.101.84x
J1745Injection, infliximab, excludes biosimilar, 10 mg97.6K$4.9M$49.843.20x
J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)599.2K$3.2M$5.332.35x
J9312Injection, rituximab, 10 mg36.1K$2.5M$68.812.20x
J1602Injection, golimumab, 1 mg, for intravenous use141.4K$2.2M$15.432.85x
J9310Injection, rituximab, 100 mg3.1K$1.9M$601.381.82x
J0897Injection, denosumab, 1 mg111.2K$1.7M$15.262.18x
J3262Injection, tocilizumab, 1 mg421.7K$1.7M$3.932.04x
J3111Injection, romosozumab-aqqg, 1 mg90.9K$683.2K$7.512.66x
99213Established patient office or other outpatient visit, 20-29 minutes9.9K$525.7K$53.072.16x
99214Established patient office or other outpatient visit, 30-39 minutes6.1K$439.0K$72.412.20x
96413Administration of chemotherapy into vein, 1 hour or less3.0K$290.9K$97.622.82x
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less4.3K$218.2K$50.863.27x
99204New patient office or other outpatient visit, 45-59 minutes775$83.1K$107.232.60x
96415Administration of chemotherapy into vein, each additional hour3.6K$76.8K$21.466.69x
96372Injection of drug or substance under skin or into muscle5.3K$68.0K$12.864.66x
20610Aspiration and/or injection of fluid from large joint1.2K$54.3K$45.533.82x
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6.5K$48.7K$7.483.34x
86481Tuberculosis test, enumeration of t-cells441$43.4K$98.342.13x
J3489Injection, zoledronic acid, 1 mg1.9K$38.0K$19.889.87x

Markup Analysis

Charge-to-Payment Ratio

2.43x

This provider submits charges 2.43 times higher than what Medicare actually pays.

What This Means

A markup ratio of 2.43x means for every $100 Medicare pays, this provider initially charges $243. This is higher than the national average.

Location

Wichita, KS

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Related

Browse
← Back to Provider Directory
State
All providers in KS →
Specialty
All Rheumatology providers →
Tool
Compare this provider →
Analysis
Fraud Watchlist →
Search
Search all providers →

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data